HM Revenue & Customs (HMRC) has launched a voluntary disclosure initiative aimed at companies that have overclaimed research and development (R&D) tax relief, marking a significant step in its ongoing ...
The pharma and life sciences industry faces a dynamic year ahead, driven by AI, sustainability, and evolving regulations. Stricter ESG reporting and economic uncertainty create new challenges. Success ...
AI, sustainability and regulatory push set to tran... The pharma and life sciences industry faces a dynamic year ahead, driven by AI, sustainability, and evolving regulations. Stricter ESG reporting ...